Rovedilol 6.25 mg (Tablet)
Unit Price: ৳ 4.00 (3 x 10: ৳ 120.00)
Strip Price: ৳ 40.00
Medicine Details
Category | Details |
---|---|
Generic | Carvedilol |
Company | Healthcare pharmaceuticals ltd |
Also available as |
Indications
- Mild heart failure treatment
- Moderate heart failure treatment
- Severe heart failure treatment
- Ischemic heart failure treatment
- Cardiomyopathic origin heart failure treatment
- Reduction of disease progression
- Cardiovascular death prevention
- Hospitalization prevention
- Medication adjustment need reduction
- ACE inhibitor intolerance management
- Digitalis non-receiving patients management
- Hydralazine or nitrate therapy management
Pharmacology
- Non-selective antagonism of beta-adrenergic receptors
- Alpha-adrenergic antagonistic activity
- Antiproliferative properties
- Scavenger of free oxidant radicals
- Treatment of hypertension
- Treatment of angina pectoris
- Treatment of congestive heart failure
Dosage & Administration
- Initial 12.5 mg once daily for hypertension
- Usual dose of 25 mg once daily for hypertension
- Maximum 50 mg daily for hypertension
- Initial 12.5 mg twice daily for angina pectoris
- Recommended 25 mg twice daily for angina pectoris
- Initial 3.125 mg twice daily for heart failure
- Maximum 25 mg twice daily for patients less than 85 kg
- Maximum 50 mg twice daily for patients over 85 kg
Interaction
- Digoxin interaction
- Rifampin interaction
- Warfarin interaction
- Clonidine interaction
Contraindications
- Decompensated heart failure with intravenous inotropic therapy
- Bronchial asthma or related bronchospastic conditions
- Second or third-degree AV block
- Sick sinus syndrome without permanent pacemaker
- Cardiogenic shock
- Severe bradycardia
Side Effects
- Postural hypotension
- Dizziness
- Headache
- Fatigue
- Gastro-intestinal disturbances
- Bradycardia
- Peripheral circulation issues
- Peripheral edema
- Dry mouth
- Eye irritation
- Impotence
- Disturbed vision
- Paresthesia
- Changes in liver enzymes
- Thrombocytopenia
- Leukopenia
- Allergic skin reactions
Pregnancy & Lactation
- Not recommended during breastfeeding
- Safety and efficacy in children not established
- Not recommended during pregnancy
- Crosses placental barrier
- Safety and efficacy in neonates not established
Precautions & Warnings
- Caution in hepatic impairment
- Clinical status monitoring after initiation and dose increase
- Renal function and heart failure assessment before dose increase
Therapeutic Class
- Alpha adrenoceptor blocking drugs
- Beta-adrenoceptor blocking drugs
- Beta-blockers
Storage Conditions
- Keep below 30°C temperature
- Away from light & moisture
- Keep out of the reach of children